Overview
Deniz Tschammler advises at the pulse of the global health markets. His clients include pharmaceutical and medical technology companies, providers of digital health solutions and their investors. Deniz assists organizations on transactions and collaborations, on market entry and access, on digitization strategies, in disputes with competitors and authorities as well as industry-specific compliance matters. He regularly advises on cross-border projects, including foreign trade law and investment control.
Deniz holds an Executive MBA from the University of St. Gallen and an LL.M. from King’s College London. He is the author of numerous health law publications. JUVE, Legal 500 and other renowned market research institutes have ranked him among the leading lawyers in the German and European health sector for many years.
Results
Deniz advised:
- Main Capital on the Acquisition of a Majority Stake in Buchner & Camp Partner
- Oakley Capital on Acquisition of Flemming Dental, Excent & Artinorway Group
- Elos Medtech on combination with Klingel Medical Group
- Myonex, Inc. to acquire Hubertus Pharmacy’s clinical trial business
- AUCTUS Capital Partners AG on the sale of PharmaLex Group
- lifespin GmbH on the conclusion of a research cooperation with Biobank Graz and the Clinical Department of Oncology at Medical University of Graz
- STADA Arzneimittel AG on a licensing collaboration with Calliditas Therapeutics AB for the approval and marketing of a novel specialty pharmaceutical candidate for the treatment of the chronic autoimmune kidney disease immunoglobulin A nephropathy (IgAN)
- Merck KgaA in negotiations on a cooperation agreement with neuroloop GmbH, an early-stage start-up company of B. Braun Group
Recognitions
- WWL, “among the highest-ranked Lawyer´s”: Life Sciences, 2024
- Chambers Europe, “up and coming” in Germany: Life Sciences, 2024
- The Best Lawyers in Germany, Pharmaceuticals Law, 2022-2024
- Thomson Reuters, “Stand-out Lawyer” – independently rated lawyers, 2023-2024
- The Legal 500 EMEA, “Next Generation Partner” in Germany: Healthcare, 2024
- JUVE Handbook of Commercial Law Firms, Recommended: Healthcare, 2024
- JUVE Handbook of Commercial Law Firms, “Rising Star”: Health (under 40), 2020-2023
- The Legal 500 EMEA, “Rising Star” in Germany: Healthcare, 2021-2023
- Euromoney LMG Rising Star EMEA: Life Sciences, 2021-2022
Community
- Association for the Promotion of the Research Center for Pharmaceutical Law at the Philipps-University of Marburg
- German-American Lawyers Association
- German Pharmaceutical Industry Association (BPI)
Credentials
Education
University of St. Gallen, Executive MBA, 2021
King’s College London, LLM, 2013
Higher Regional Court of Wiesbaden, Second State Examination, 2012
Philipps University of Marburg, Dr. jur., 2011
Goethe University of Frankfurt, First State Examination, 2008
Universities of Frankfurt and Lyon, Diploma in French Law, 2007
Admissions
Germany
Languages
English
German
